| Literature DB >> 32108223 |
David B Sykes1, Casey O'Connell2, Wilfried Schroyens3.
Abstract
The TEMPI syndrome is a rare and acquired disorder characterized by 5 salient features, which compose its name: (1) telangiectasias; (2) elevated erythropoietin and erythrocytosis; (3) monoclonal gammopathy; (4) perinephric fluid collections; and (5) intrapulmonary shunting. Complete resolution of symptoms following treatment with plasma cell-directed therapy supports the hypothesis that the monoclonal antibody is causal and pathogenic. Understanding the basis of the TEMPI syndrome will depend on the identification of additional patients and a coordinated international effort.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32108223 DOI: 10.1182/blood.2019004216
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113